| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6002218 | Thrombosis Research | 2014 | 7 Pages |
Abstract
Our finding suggests that PGx-guided warfarin dosing is unlikely to be a cost-effective intervention in Thailand. This evidence assists policy makers and clinicians in efficiently allocating scarce resources.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Huey Yi Chong, Surasak Saokaew, Kuntika Dumrongprat, Unchalee Permsuwan, David Bin-Chia Wu, Piyamitr Sritara, Nathorn Chaiyakunapruk,